We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


PolyTherics to Receive Knowledge Transfer Partnership Programme Funding

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "PolyTherics to Receive Knowledge Transfer Partnership Programme Funding"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
PolyTherics Limited has announced that the Technology Strategy Board (TSB) had offered The School of Pharmacy, University of London, a Knowledge Transfer Partnership (KTP) grant that will be used to part-fund work being undertaken in collaboration with PolyTherics.

The funding will be used to employ a KTP Associate who will develop and optimize the use of mass spectroscopy to confirm the location of polyethylene (glycol) (PEG) on proteins and peptides that are being developed as long-acting drugs by PolyTherics. The project is scheduled to run for 24 months and the TSB is providing just over £78,000 to support the work.

PolyTherics has substantial expertise in the targeted modification of biologic compounds with therapeutic potential. Through its platform of site specific technologies to conjugate PEG to proteins and peptides, the Company systematically optimizes the performance of biologics for administration as injectable drugs. Its most advanced programme is an interferon alpha PEGylated using its HiPEG™ technology that is being developed as a biobetter medicine. The Company has recently launched a new website which provides the latest information on all its technologies.

Dr Keith Powell, Chief Executive Officer at PolyTherics, commented “We are delighted that The School of Pharmacy has received this funding to support our partnership with them in this challenging project.”

Dr Bill Lindsay, Business Development Manager at the School of Pharmacy, commented “We are very pleased to receive this award which will provide a great opportunity to add to the knowledge base and commercial potential of an area in which PolyTherics is at the forefront.”